Shari Meyerson

Dr. Shari Meyerson serves as Professor of Surgery, Chief of the Section of Thoracic Surgery, and Director of the Thoracic Surgery Training Program at the University of Kentucky College of Medicine. She provides surgical leadership to the thoracic oncology team at UK Markey Cancer Center and is nationally recognized for her expertise in thoracic surgery and surgical education.

Her educational background includes:

• Medical Degree: University of Chicago Pritzker School of Medicine (1996)
• Residency: General Surgery, University of Chicago Hospitals
• Fellowship: Thoracic Surgery, Duke University Medical Center
• Research Fellowship: Vascular Surgery, University of Chicago
• Master of Education: University of Cincinnati (2015)

Dr. Meyerson's clinical focus centers on lung cancer treatment with dual emphasis on curative outcomes and quality-of-life preservation. She specializes in minimally invasive techniques including VATS and manages complex thoracic conditions spanning esophageal, mediastinal, and pleural pathologies. Her surgical approach prioritizes patient-centered care through comprehensive preoperative counseling and minimally disruptive interventions.

Academically, she has pioneered innovative surgical education methodologies, previously directing residency programs at Northwestern University for nearly a decade. Her 2015 Master of Education degree enhanced evidence-based teaching strategies that now shape thoracic surgery training nationwide. Patient satisfaction data reflects exceptional clinical performance with a 4.95/5 rating across 12 reviews through 2024.

As program director, she oversees surgical resident training with particular focus on competency-based assessment and simulation-enhanced curricula. Her mentorship philosophy emphasizes technical excellence combined with compassionate communication skills development.

Dr. Meyerson leads the Lung and Thoracic Cancer Team at UK Markey Cancer Center, coordinating multidisciplinary care across Lexington and Somerset locations. Her clinical team integrates advanced diagnostics with personalized treatment pathways for lung nodules, malignant tumors, and benign thoracic conditions.